Merck (MRK) PT Raised to $145 at Cantor Fitzgerald - Outstanding ESMO Expected

October 8, 2026 7:16 AM EDT Send to a Friend
Cantor Fitzgerald analyst Carter Gould raised the price target on Merck (NYSE: MRK) to $145.00 (from $120.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login